Neuravi, a company out of*Galway, Ireland, won the European CE Mark for its EmboTrap II Revascularization Device to treat Acute Ischemic stroke. The device is made to trap clots, deliver TICI 2b-3 reperfusion, and consistently grab onto the Clot as it’s ******* from the patient.
Based on the original EmboTrap that came to market in Europe last year, the new device is intended to treat a greater range of Clot lengths via a .021″ microcatheter.
“The EmboTrap platform has been a great addition to my clinical practice. In my first nine cases using the device, I was able to get TICI 2b-3 reperfusion in one pass. **w with the EmboTrap II, I’ve had comparably good results when treating longer occlusions,” said Christian Taschner, M.D., professor of Radiology, University of Freiburg, Germany, in a press release. “In fact, in early evaluations of the EmboTrap II 5×33 at six centers, 16 of 17 cases resulted in TICI 2b-3 flow. The open design of the device helps trap Clot inside and also makes it quite flexible, which is important when removing Clot from the arteries of the brain.”
09-12-2016, 02:40 PM
EmboTrap II Clot Retriever for Acute Ischemic Stroke Cleared in Europe
Neuravi, a company out of*Galway, Ireland, won the European CE Mark for its EmboTrap II Revascularization Device to treat Acute Ischemic stroke. The device is made to trap clots, deliver TICI 2b-3 reperfusion, and consistently grab onto the Clot as it’s ******* from the patient.
العرض الشجري